Company / Operating Margin
Korro Bio, Inc. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-4047.1%
FY2025
5-year range
-4047.1% / -71.4%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -578% YoY in FY2025, a notable deviation from the 4-year average annual change of -322%.
Based on SEC 10-K filings.
-4047.1% in FY2025 with a 5-year CAGR of -3975.7%.
Declined from -74.5% to -4047.1% over the past 4 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -3449.8pp
- 5-Year Change
- -3975.7pp
- 10-Year Change
- -
Key checks
Key Insights
- Peak operating margin was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4047.1% | - |
| FY2024 | - | - |
| FY2022 | -597.3% | -701.9% |
| FY2021 | -74.5% | -4.3% |
| FY2020 | -71.4% | -6.2% |
| FY2019 | -67.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026